Resultados de búsqueda - Boo, Irene
- Mostrando 1 - 12 Resultados de 12
-
1
-
2
-
3
-
4
-
5
Enhancing the antigenicity and immunogenicity of monomeric forms of hepatitis C virus E2 for use as a preventive vaccine por Center, Rob J., Boo, Irene, Phu, Lilian, McGregor, Joey, Poumbourios, Pantelis, Drummer, Heidi E.
Publicado 2020Texto -
6
An Optimized Hepatitis C Virus E2 Glycoprotein Core Adopts a Functional Homodimer That Efficiently Blocks Virus Entry por McCaffrey, Kathleen, Boo, Irene, Owczarek, Catherine M., Hardy, Matthew P., Perugini, Matthew A., Fabri, Louis, Scotney, Pierre, Poumbourios, Pantelis, Drummer, Heidi E.
Publicado 2017Texto -
7
Escape of Hepatitis C Virus from Epitope I Neutralization Increases Sensitivity of Other Neutralization Epitopes por Gu, Jun, Hardy, Joshua, Boo, Irene, Vietheer, Patricia, McCaffrey, Kathleen, Alhammad, Yousef, Chopra, Abha, Gaudieri, Silvana, Poumbourios, Pantelis, Coulibaly, Fasséli, Drummer, Heidi E.
Publicado 2018Texto -
8
Virus-Like Particles Containing the E2 Core Domain of Hepatitis C Virus Generate Broadly Neutralizing Antibodies in Guinea Pigs por McGregor, Joey, Hardy, Joshua M., Lay, Chan-Sien, Boo, Irene, Piontek, Michael, Suckow, Manfred, Coulibaly, Fasséli, Poumbourios, Pantelis, Center, Rob J., Drummer, Heidi E.
Publicado 2022Texto -
9
The core domain of hepatitis C virus glycoprotein E2 generates potent cross‐neutralizing antibodies in guinea pigs por Vietheer, Patricia T., Boo, Irene, Gu, Jun, McCaffrey, Kathleen, Edwards, Stirling, Owczarek, Catherine, Hardy, Matthew P., Fabri, Louis, Center, Rob J., Poumbourios, Pantelis, Drummer, Heidi E.
Publicado 2017Texto -
10
Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence por Hartley, Gemma E., Edwards, Emily S.J., Aui, Pei M., Varese, Nirupama, Stojanovic, Stephanie, McMahon, James, Peleg, Anton Y., Boo, Irene, Drummer, Heidi E., Hogarth, P. Mark, O’Hehir, Robyn E., van Zelm, Menno C.
Publicado 2020Texto -
11
Dimeric IgA is a specific biomarker of recent SARS-CoV-2 infection por Drummer, Heidi E, Van, Huy, Klock, Ethan, Zheng, Shuning, Wei, Zihui, Boo, Irene, Center, Rob J, Li, Fan, Bhat, Purnima, Ffrench, Rosemary, Lau, Jillian SY, McMahon, James, Laeyendecker, Oliver, Fernandez, Reinaldo E., Manabe, Yukari C., Klein, Sabra L., Quinn, Thomas C., Anderson, David A.
Publicado 2021Texto -
12
A point-of-care lateral flow assay for neutralising antibodies against SARS-CoV-2 por Fulford, Thomas S., Van, Huy, Gherardin, Nicholas A., Zheng, Shuning, Ciula, Marcin, Drummer, Heidi E., Redmond, Samuel, Tan, Hyon-Xhi, Boo, Irene, Center, Rob J., Li, Fan, Grimley, Samantha L., Wines, Bruce D., Nguyen, Thi H.O., Mordant, Francesca L., Ellenberg, Paula, Rowntree, Louise C., Kedzierski, Lukasz, Cheng, Allen C., Doolan, Denise L., Matthews, Gail, Bond, Katherine, Hogarth, P. Mark, McQuilten, Zoe, Subbarao, Kanta, Kedzierska, Katherine, Juno, Jennifer A., Wheatley, Adam K., Kent, Stephen J., Williamson, Deborah A., Purcell, Damian F.J., Anderson, David A., Godfrey, Dale I.
Publicado 2021Texto